We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.74%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$6.79B
AUM Growth
+$1.29B
(+24%)
Cap. Flow
+$933M
Cap. Flow
% of AUM
13.74%
Top 10 Holdings %
Top 10 Hldgs %
15.83%
Holding
1,205
New
433
Increased
209
Reduced
253
Closed
295
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lazard
LAZ
|
+$67.3M |
| 2 |
PPG Industries
PPG
|
+$49.7M |
| 3 |
Apple
AAPL
|
+$46.8M |
| 4 |
Micron Technology
MU
|
+$42.1M |
| 5 |
H&R Block
HRB
|
+$41.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SC
SANTANDER CONSUMER USA HOLDINGS INC
SC
|
+$54.9M |
| 2 |
Blackstone
BX
|
+$36.2M |
| 3 |
SNDK
SANDISK CORP
SNDK
|
+$35.8M |
| 4 |
International Flavors & Fragrances
IFF
|
+$34.2M |
| 5 |
KKR & Co
KKR
|
+$33.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 12.8% |
| 2 | Communication Services | 12.26% |
| 3 | Healthcare | 12.21% |
| 4 | Materials | 11.4% |
| 5 | Financials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
CF Industries
CF
$19.2B
| $10.8M | 0.16% |
223,715
| – | – |
|
|
ESV
177
DELISTED
Ensco Rowan plc
ESV
| $10.8M | 0.16% |
+48,368
| New | +$10M |
|
178
Pfizer
PFE
$140B
| $10.7M | 0.16% |
379,677
-120,141
| -24% | -$3.42M |
|
179
Cenovus Energy
CVE
$54.6B
| $10.4M | 0.15% |
322,443
+276,527
| +602% | +$8.22M |
|
|
CAMP
180
DELISTED
CalAmp Corp.
CAMP
| $10.1M | 0.15% |
20,355
+6,971
| +52% | +$3.27M |
|
|
SHPG
181
DELISTED
Shire pic
SHPG
| $10.1M | 0.15% |
42,889
-120,889
| -74% | -$21M |
|
|
HDS
182
DELISTED
HD Supply Holdings, Inc.
HDS
| $10.1M | 0.15% |
354,622
+221,048
| +165% | +$5.88M |
|
183
NRG Energy
NRG
$29.8B
| $9.93M | 0.15% |
+266,876
| New | +$9.19M |
|
|
XL
184
DELISTED
XL Group Ltd.
XL
| $9.79M | 0.14% |
299,092
-355,944
| -54% | -$11.4M |
|
185
Minerals Technologies
MTX
$2.31B
| $9.67M | 0.14% |
147,388
+30,941
| +27% | +$1.93M |
|
|
KND
186
DELISTED
Kindred Healthcare
KND
| $9.6M | 0.14% |
+415,700
| New | +$10.2M |
|
|
AHL
187
DELISTED
ASPEN Insurance Holding Limited
AHL
| $9.42M | 0.14% |
207,406
+19,295
| +10% | +$864K |
|
188
Gilead Sciences
GILD
$161B
| $9.4M | 0.14% |
113,423
+20,999
| +23% | +$1.63M |
|
|
RCPT
189
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $9.36M | 0.14% |
+219,700
| New | +$7.59M |
|
190
Cigna
CI
$76.6B
| $9.16M | 0.13% |
+99,552
| New | +$8.54M |
|
191
Capital One
COF
$124B
| $9.11M | 0.13% |
110,334
+103,079
| +1,421% | +$8.01M |
|
|
ENDP
192
DELISTED
Endo International plc
ENDP
| $8.59M | 0.13% |
122,611
+113,976
| +1,320% | +$7.62M |
|
193
Amgen
AMGN
$203B
| $8.52M | 0.13% |
+71,966
| New | +$8.33M |
|
|
ALXN
194
DELISTED
Alexion Pharmaceuticals
ALXN
| $8.32M | 0.12% |
53,271
-8,299
| -13% | -$1.31M |
|
|
CQH
195
DELISTED
Cheniere Energy Partners LP Holdings LLC
CQH
| $8.29M | 0.12% |
333,558
-865,810
| -72% | -$20.5M |
|
196
Ovintiv
OVV
$17.5B
| $8.29M | 0.12% |
69,886
+19,225
| +38% | +$2.23M |
|
|
MDVN
197
DELISTED
MEDIVATION, INC.
MDVN
| $8.28M | 0.12% |
214,790
+188,550
| +719% | +$6.36M |
|
|
INVX
198
Innovex International
INVX
$1.87B
| $8.25M | 0.12% |
+75,497
| New | +$8.11M |
|
|
OPEN
199
DELISTED
OPENTABLE,INC COMMON STOCK
OPEN
| $8.24M | 0.12% |
+79,572
| New | +$6.07M |
|
200
SEI Investments
SEIC
$11.9B
| $8.21M | 0.12% |
250,427
-451,812
| -64% | -$14.6M |
|
Similar funds
Marshall Wace's Q2 2014 Portfolio in Review
As of Q2 2014, Marshall Wace held 1,205 positions worth $6.79B, up 24% from $5.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $933M of net new capital in Q2 2014, opening 433 new positions and adding to 209 existing holdings. Its largest new stake was H&R Block: 1,400,000 shares worth $46.9M.
By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 13% a quarter earlier, followed by Communication Services and Healthcare.
On the sell side, the largest reduction was SANDISK CORP, an estimated $35.8M trimmed.
- Marshall Wace's largest Q2 2014 buy was H&R Block: 1,400,000 shares worth $46.9M.
- Marshall Wace added most to Lazard in Q2 2014, an estimated $67.3M increase.
- Marshall Wace's biggest Q2 2014 reduction was SANDISK CORP, cutting an estimated $35.8M.
- Marshall Wace fully exited SANTANDER CONSUMER USA HOLDINGS INC in Q2 2014, selling an estimated $54.9M.
- Marshall Wace's ten largest holdings make up 16% of its $6.79B portfolio in Q2 2014.
- Marshall Wace opened 433 new positions and closed 295 in Q2 2014.
- Marshall Wace's portfolio value rose 24% quarter-over-quarter to $6.79B.
Based on Marshall Wace's 13F filing for Q2 2014, filed 14 Aug 2014.